Related Experiment Videos
[Specific curative effects of nitrosourea drugs on tumor cells with Mer--phenotype in Chinese]
1Institute of Radiation Medicine, Academy of Military Medical Sciences, Beijing, China.
Abstract:
O6-Methylguanine DNA methyltransferase (O6-MT) activity and cellular sensitivity to nitrosourea drugs of 10 kinds of tumor cell strains derived from Chinese patients were measured by 3H radioactivity and colony-forming ability, respectively. The results in vitro showed that nimustine (Nim) 25 micrograms.ml-1 and carmustine (Car) 20 micrograms.ml-1 exhibited specific killing effects on Mer-phenotype tumor cells characterized by low O6-MT activity. In vivo both Nim and Car (25 mg.kg-1.wk-1 x 4 wk, ip) had specific curative ability to Mer- tumor cells implanted in nude mice. These findings suggested that assay of O6- MT activity in tumor biopsy could be used as a predictable guide to human tumor chemotherapy with nitrosourea compounds.
Insights
Assessing O6-Methylguanine DNA methyltransferase (O6-MT) activity predicts tumor cell response to nitrosourea chemotherapy. Low O6-MT activity indicates sensitivity to drugs like nimustine and carmustine.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Context:
- Nitrosourea drugs are a class of chemotherapeutic agents.
- Tumor cell resistance to chemotherapy is a significant clinical challenge.
- O6-Methylguanine DNA methyltransferase (O6-MT) is an enzyme involved in DNA repair.
Purpose:
- To investigate the relationship between O6-Methylguanine DNA methyltransferase (O6-MT) activity and cellular sensitivity to nitrosourea drugs.
- To evaluate the efficacy of nimustine (Nim) and carmustine (Car) in Mer-phenotype tumor cells.
- To determine if O6-MT activity can serve as a predictive biomarker for nitrosourea chemotherapy response.
Summary:
- O6-Methylguanine DNA methyltransferase (O6-MT) activity and cellular sensitivity to nimustine (Nim) and carmustine (Car) were measured in 10 tumor cell strains from Chinese patients.
- In vitro and in vivo studies demonstrated that nimustine and carmustine specifically target Mer-phenotype tumor cells with low O6-MT activity.
- Nimustine and carmustine showed specific curative effects on Mer- tumor cells implanted in nude mice.
Impact:
- Assaying O6-MT activity in tumor biopsies can guide human tumor chemotherapy decisions involving nitrosourea compounds.
- This finding may lead to more personalized and effective cancer treatment strategies.
- Potential for improved patient outcomes through targeted chemotherapy selection based on O6-MT levels.